Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

Immune Regulation Raises £40.6m Series B Equity Financing (2020-09-21)
Series B round led by Morningside Ventures provides foundation to accelerate the drug development of first-in-class immune-resetting therapies. Immune Regulation Limited (“Immune Regulation”), a US and UK based clinical stage biotechnology company, today annou...
Illumina to Acquire Grail for $8b in Cash & Shares (2020-09-21)
> Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and Enable Better Outcomes > Adds Multi-Disciplinary Team and Capabilities Harnessing the Power of Next-Generation Sequencing...
Compass Pathways Prices $127.5m IPO at Nasdaq (2020-09-18)
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of its upsized initial public offering in the United States of 7,500,00...
Novo & Sanofi Lead $83m Series C of Lava Therapeutics (2020-09-17)
- New investment to support advancement of powerful bispecific Gamma-Delta T cell engager programs for the treatment of a broad range of cancers - Leading global life sciences venture has invested approx US$1 billion in last two years Novo Ventures, the ven...
BioNTech to Acquire Marburg Production Site from Novartis (2020-09-17)
> Facility will become one of the largest mRNA manufacturing sites in Europe and the third site in the BioNTech manufacturing network in Germany expected to produce BNT162 for global supply > Expected to be fully operational in the first half 2021 with an annual...
InflaRx: Thomas Taapken New CFO, Jordan Zwick Promoted (2020-09-17)
> Thomas Taapken, Ph.D. appointed Chief Financial Officer > Jordan Zwick promoted to Chief Strategy Officer InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, toda...
Qiagen Acquires Remaining Shares of NeuMoDx for $248m (2020-09-17)
> Transaction strengthens QIAGEN’s leadership position in automated molecular testing > QIAGEN acquires remaining 80.1% stake in NeuMoDx Molecular, Inc. for $248 million > Medium- and high-throughput NeuMoDx automation solutions based on PCR testing technolog...
Moderna: Dan Staner New VP & Managing Director, Switzerland (2020-09-16)
> Dan Staner appointed as Vice President and Managing Director, Switzerland > Reinforces Moderna’s commitment to Europe Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generatio...
Graphite Bio Launches with $45m Series A Financing (2020-09-16)
-- Next-generation gene editing company launched by Versant Ventures with additional backing by Samsara BioCapital -- -- Core technology from Stanford founders Matt Porteus and Maria Grazia Roncarolo -- -- Josh Lehrer joins as CEO -- Graphite Bio today a...
Polyneuron Adds CHF14m, Bringing Series A to CH36.5m (2020-09-16)
HBM Healthcare Investments joins lead investor Sofinnova Partners and New Enterprise Associates in consortium Polyneuron Pharmaceuticals AG, a clinical stage developer of a new class of antigen-specific polymers for the treatment of patients with serious autoi...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]